Page last updated: 2024-11-02

moxonidine and Bone Diseases, Metabolic

moxonidine has been researched along with Bone Diseases, Metabolic in 1 studies

moxonidine: structure given in first source

Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.

Research Excerpts

ExcerptRelevanceReference
"To compare the effect of 12 months of treatment with moxonidine or bisoprolol on telomerase activity (TA) and parameters characterizing the arterial wall state in postmenopausal women with arterial hypertension (AH) and osteopenia."9.51Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study. ( Bazaeva, E; Dudinskaya, E; Eruslanova, K; Kotovskaya, Y; Larina, V; Matchekhina, L; Sharashkina, N; Tkacheva, O, 2022)
"To compare the effect of 12 months of treatment with moxonidine or bisoprolol on telomerase activity (TA) and parameters characterizing the arterial wall state in postmenopausal women with arterial hypertension (AH) and osteopenia."5.51Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study. ( Bazaeva, E; Dudinskaya, E; Eruslanova, K; Kotovskaya, Y; Larina, V; Matchekhina, L; Sharashkina, N; Tkacheva, O, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dudinskaya, E1
Tkacheva, O1
Bazaeva, E1
Matchekhina, L1
Eruslanova, K1
Sharashkina, N1
Kotovskaya, Y1
Larina, V1

Trials

1 trial available for moxonidine and Bone Diseases, Metabolic

ArticleYear
Influence of Moxonidine and Bisoprolol on Morphofunctional Condition of Arterial Wall and Telomerase Activity in Postmenopausal Women with Arterial Hypertension and Osteopenia. The Results from a Moscow Randomized Study.
    Cardiovascular drugs and therapy, 2022, Volume: 36, Issue:6

    Topics: Antihypertensive Agents; Bisoprolol; Bone Diseases, Metabolic; Carotid Intima-Media Thickness; Femal

2022